Kalekim Kimyevi Maddeler Sanayi & Ticaret AS Free Cash Flow Generation Index

Latest as of December 2025: 0.73x

Kalekim Kimyevi Maddeler Sanayi & Ticaret AS free cash flow generation index. Kalekim Kimyevi Maddeler Sanayi & Ticaret AS (KLKIM) has a Free Cash Flow Generation Index of 0.73x as of December 2025. Free cash flow of TL600.20 Million represents 1% of operating cash flow (TL822.16 Million).

FCF Generation Index

0.73x
Free Cash Flow / Operating CF

Free Cash Flow

TL600.20 Million
TRY

Operating Cash Flow

TL822.16 Million
TRY

Capital Expenditures

TL221.96 Million
TRY

Free Cash Flow Generation Index of Kalekim Kimyevi Maddeler Sanayi & Ticaret AS (2019–2025)

Free cash flow generation index of Kalekim Kimyevi Maddeler Sanayi & Ticaret AS from 2019 to 2025. Historical FCF Generation Index trend for Kalekim Kimyevi Maddeler Sanayi & Ticaret AS across 7 annual periods. See KLKIM FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Kalekim Kimyevi Maddeler Sanayi & Ticaret AS Free Cash Flow Generation Index by Year (2019–2025)

Kalekim Kimyevi Maddeler Sanayi & Ticaret AS free cash flow generation index by year from 2019 to 2025. Year-by-year Free Cash Flow Generation Index for Kalekim Kimyevi Maddeler Sanayi & Ticaret AS. For the full cash flow conversion analysis, see KLKIM cash flow metrics.

Year FCG Index Free Cash Flow (TRY) Operating CF Capital Expenditures YoY Change
2025 0.58x TL1.14 Billion TL1.97 Billion TL834.11 Million ▲ +91.2%
2024 0.30x TL257.78 Million TL854.98 Million TL597.20 Million ▲ +4.6%
2023 0.29x TL205.24 Million TL712.33 Million TL507.10 Million ▼ -55.9%
2022 0.65x TL165.05 Million TL252.62 Million TL87.57 Million ▼ -12.0%
2021 0.74x TL149.23 Million TL200.94 Million TL47.81 Million ▲ +1.5%
2020 0.73x TL87.62 Million TL119.80 Million TL25.48 Million ▼ -36.3%
2019 1.15x TL112.78 Million TL98.15 Million TL14.63 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).